Literature DB >> 16338022

Virology of hepatitis B and C viruses and antiviral targets.

Jean-Michel Pawlotsky1.   

Abstract

Hepatitis B and C viruses belong to two distinct virus families, the Hepadnaviridae and the Flaviviridae, respectively, and have different virological characteristics. Better knowledge of their lifecycles and variability offers the opportunity to develop novel therapeutic approaches and classes of drugs. The issue of cccDNA clearance, however, remains in hepatitis B treatment, whereas HCV infection is curable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338022     DOI: 10.1016/j.jhep.2005.11.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Inhibition of hepatitis C virus NS5B polymerase by S-trityl-L-cysteine derivatives.

Authors:  Daniel B Nichols; Guy Fournet; K R Gurukumar; Amartya Basu; Jin-Ching Lee; Naoya Sakamoto; Frank Kozielski; Ira Musmuca; Benoît Joseph; Rino Ragno; Neerja Kaushik-Basu
Journal:  Eur J Med Chem       Date:  2012-01-12       Impact factor: 6.514

2.  New direct-acting antivirals in the development for hepatitis C virus infection.

Authors:  Paul J Pockros
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 3.  Viral hepatitis in HIV infection.

Authors:  Margaret James Koziel; Marion G Peters
Journal:  N Engl J Med       Date:  2007-04-05       Impact factor: 91.245

4.  Drugs in development for viral hepatitis: care and caution.

Authors:  Paul J Pockros
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

Review 5.  Therapeutic Advances in Viral Hepatitis A-E.

Authors:  Navroop Nagra; Richard A Kozarek; Blaire E Burman
Journal:  Adv Ther       Date:  2022-02-27       Impact factor: 3.845

6.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

Review 7.  Hepatitis B virus therapy: What's the future holding for us?

Authors:  Sobia Manzoor; Muhammad Saalim; Muhammad Imran; Saleha Resham; Javed Ashraf
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

8.  Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.

Authors:  Jessica P Hwang; Mark R Somerfield; Devena E Alston-Johnson; Donna R Cryer; Jordan J Feld; Barnett S Kramer; Anita L Sabichi; Sandra L Wong; Andrew S Artz
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

Review 9.  Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.

Authors:  Rodolfo Castro; Hugo Perazzo; Beatriz Grinsztejn; Valdilea G Veloso; Chris Hyde
Journal:  Int J Hepatol       Date:  2015-11-29

10.  Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals.

Authors:  Lisa Barrett; Maureen Gallant; Constance Howley; M Ian Bowmer; Geri Hirsch; Kevork Peltekian; Michael Grant
Journal:  BMC Immunol       Date:  2008-06-13       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.